查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606678

深部靜脈疾病治療設備市場：按類型、最終用戶分類 - 全球預測 2025-2030

Deep Venous Disease Treatment Devices Market by Type (Compression Device, Peripheral Vascular Stent, Thrombectomy & Thrombolysis Device), End User (Ambulatory Surgical Centres, Hospitals & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年深部靜脈疾病治療設備市場價值為10.9億美元，預計到2024年將達到11.7億美元，複合年成長率為7.64%，到2030年將達到18.3億美元。

深部靜脈疾病（DVD）治療設備包括旨在診斷和治療影響深部靜脈系統的疾病的各種醫療設備和技術，例如深層靜脈栓塞症（DVT）和慢性靜脈功能不全（CVI）。久坐生活方式的增加、人口老化以及心血管疾病的增加（增加靜脈疾病的風險）推動了對這些設備的需求。治療範圍包括醫院、專科診所和家庭保健，強調個別化治療方法的重要性。最終使用者包括醫療保健提供者、醫療專業人員和尋求微創治療解決方案的患者。影響市場的關鍵成長要素是設備技術的進步、早期診斷意識的提高以及對非侵入性治療方案的需求。新治療方法的出現和有利的監管環境為創新和成長提供了潛在的機會。市場參與企業可以探索策略聯盟並投資於研發，以開發下一代靜脈注射設備，以提高療效和患者治療效果。然而，高昂的治療成本、嚴格的監管要求以及缺乏熟練專業人員等挑戰可能會阻礙市場擴張。發展中地區的經濟限制進一步抑制了成長潛力。為了緩解這些挑戰，公司可以專注於具有成本效益的產品開發和加強專業培訓的教育計劃。創新成熟的領域包括穿戴式監測設備、人工智慧輔助診斷和生物整合治療解決方案，以促進更快、更全面的復原過程。主要研究工作可以集中在了解 DVD 的分子機制和增強當前設備的生物相容性和功能。市場格局競爭激烈且充滿活力，其特點是技術快速進步和不斷變化的醫療保健需求，要求市場參與者在利用新機會的同時保持敏捷性和主動性。

主要市場統計
基準年[2023] 10.9億美元
預測年份 [2024] 11.7億美元
預測年份 [2030] 18.3億美元
複合年成長率（%） 7.64%

市場動態：快速發展的深部靜脈疾病治療設備市場的關鍵市場洞察

供需的動態交互作用正在改變深部靜脈疾病治療設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 深部靜脈疾病在全球呈上升趨勢
    • 提高預防設備意識
  • 市場限制因素
    • 替代治療方案的可用性
  • 市場機會
    • 深部靜脈疾病治療設備的持續研發活動
    • 個體化血管帳篷及間歇式氣動加壓裝置的研發
  • 市場挑戰
    • 缺乏熟練的專業人員

波特五力：開拓深部靜脈疾病治療設備市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解深部靜脈疾病治療設備市場的外部影響

外部宏觀環境因素在塑造深部靜脈疾病治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解深部靜脈注射疾病治療器材市場的競爭狀況

深部靜脈疾病治療設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣深部靜脈疾病治療設備市場供應商的績效評估

FPNV 定位矩陣是評估深部靜脈疾病治療設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃深部靜脈疾病治療設備市場的成功之路

對於希望加強在全球市場的影響力的公司來說，對深部靜脈疾病治療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球深部靜脈疾病發生率增加
      • 提高對預防設備的認知
    • 抑制因素
      • 替代治療方案的可用性
    • 機會
      • 深部靜脈疾病治療設備的持續研發活動
      • 個性化血管帳篷和間歇式氣動加壓裝置的開發
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章深部靜脈疾病治療設備市場：依類型

  • 壓縮裝置
  • 周邊血管支架
  • 血栓切除和溶栓裝置

第7章深部靜脈疾病治療設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院/診所

第8章北美和南美深部靜脈疾病治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區深部靜脈疾病治療器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的深部靜脈疾病治療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acandis GmbH
  • Alma Lasers GMBH
  • Andratec GmbH
  • AngioDynamics, Inc.
  • Becton, Dickinson, and Company
  • Biolitec AG
  • Boston Scientific Corporation
  • Cardinal Health
  • Imperative Care
  • Innova Vascular, Inc.
  • Johnson & Johnson Medical NV
  • Kavya Pharma
  • Koninklijke Philips NV
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Penumbra Inc.
  • Stryker Corporation
  • Surmodics, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-5C6F41F5AF43

The Deep Venous Disease Treatment Devices Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 1.83 billion by 2030.

Deep Venous Disease (DVD) Treatment Devices encompass a range of medical devices and technologies aimed at diagnosing and treating conditions affecting the deep venous system, including deep vein thrombosis (DVT) and chronic venous insufficiency (CVI). The necessity for these devices is driven by the increasing prevalence of sedentary lifestyles, aging populations, and rising incidences of cardiovascular diseases, which heighten the risk for venous disorders. Applications extend to hospitals, specialty clinics, and home healthcare settings, emphasizing the importance of tailored treatment approaches. End-users include healthcare providers, medical professionals, and patients seeking minimally invasive therapeutic solutions. Significant growth factors influencing the market are advancements in device technology, growing awareness on early diagnosis, and the demand for non-invasive treatment options. The emergence of novel therapies and favorable regulatory landscapes present potential opportunities for innovation and growth. Market participants can explore strategic collaborations and invest in R&D to develop next-generation venous devices that enhance efficacy and patient outcomes. However, challenges such as high treatment costs, stringent regulatory requirements, and the dearth of skilled professionals may pose hurdles to market expansion. Economic constraints in developing regions further impede growth potential. To mitigate these challenges, companies could focus on cost-effective product development and educational programs to bolster professional training. Areas ripe for innovation include wearable monitoring devices, artificial intelligence-assisted diagnostics, and biologically integrated treatment solutions that promote faster and more holistic healing processes. Key research efforts can pivot towards understanding the molecular mechanisms of DVD and enhancing current device biocompatibility and function. The market landscape is competitive and dynamic, characterized by rapid technological advancements and evolving healthcare demands, mandating market players to stay agile and forward-thinking to maintain a competitive edge while tapping into emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.09 billion
Estimated Year [2024] USD 1.17 billion
Forecast Year [2030] USD 1.83 billion
CAGR (%) 7.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deep Venous Disease Treatment Devices Market

The Deep Venous Disease Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of deep vein diseases across the world
    • Rising awareness about preventative devices
  • Market Restraints
    • Availability of alternative treatment options
  • Market Opportunities
    • Ongoing research and development activities for deep vein disease devices
    • Development of personalized vascular tents and intermittent pneumatic compression devices
  • Market Challenges
    • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Deep Venous Disease Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deep Venous Disease Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deep Venous Disease Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deep Venous Disease Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deep Venous Disease Treatment Devices Market

A detailed market share analysis in the Deep Venous Disease Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deep Venous Disease Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deep Venous Disease Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deep Venous Disease Treatment Devices Market

A strategic analysis of the Deep Venous Disease Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deep Venous Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Alma Lasers GMBH, Andratec GmbH, AngioDynamics, Inc., Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Cardinal Health, Imperative Care, Innova Vascular, Inc., Johnson & Johnson Medical NV, Kavya Pharma, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Penumbra Inc., Stryker Corporation, Surmodics, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Deep Venous Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Compression Device, Peripheral Vascular Stent, and Thrombectomy & Thrombolysis Device.
  • Based on End User, market is studied across Ambulatory Surgical Centres and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of deep vein diseases across the world
      • 5.1.1.2. Rising awareness about preventative devices
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for deep vein disease devices
      • 5.1.3.2. Development of personalized vascular tents and intermittent pneumatic compression devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Deep Venous Disease Treatment Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Compression Device
  • 6.3. Peripheral Vascular Stent
  • 6.4. Thrombectomy & Thrombolysis Device

7. Deep Venous Disease Treatment Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centres
  • 7.3. Hospitals & Clinics

8. Americas Deep Venous Disease Treatment Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Deep Venous Disease Treatment Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Deep Venous Disease Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Alma Lasers GMBH
  • 4. Andratec GmbH
  • 5. AngioDynamics, Inc.
  • 6. Becton, Dickinson, and Company
  • 7. Biolitec AG
  • 8. Boston Scientific Corporation
  • 9. Cardinal Health
  • 10. Imperative Care
  • 11. Innova Vascular, Inc.
  • 12. Johnson & Johnson Medical NV
  • 13. Kavya Pharma
  • 14. Koninklijke Philips N.V.
  • 15. Medtronic PLC
  • 16. Merit Medical Systems, Inc.
  • 17. Nipro Corporation
  • 18. Penumbra Inc.
  • 19. Stryker Corporation
  • 20. Surmodics, Inc.
  • 21. Teleflex Incorporated
  • 22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COMPRESSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY THROMBECTOMY & THROMBOLYSIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. DEEP VENOUS DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023